Proshares Trust (ZBIO) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to -$1.22.
- Zenas BioPharma's EPS (Weighted Average and Diluted) rose 7569.72% to -$1.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.67, marking a year-over-year increase of 12163.66%. This contributed to the annual value of -$12.22 for FY2024, which is 4959.08% up from last year.
- Per Zenas BioPharma's latest filing, its EPS (Weighted Average and Diluted) stood at -$1.22 for Q3 2025, which was up 7569.72% from -$1.25 recorded in Q2 2025.
- Over the past 5 years, Zenas BioPharma's EPS (Weighted Average and Diluted) peaked at $1.96 during Q3 2023, and registered a low of -$24.23 during Q2 2024.
- In the last 3 years, Zenas BioPharma's EPS (Weighted Average and Diluted) had a median value of -$4.28 in 2024 and averaged -$7.64.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 35612.24% in 2024, then skyrocketed by 9552.82% in 2025.
- Quarter analysis of 3 years shows Zenas BioPharma's EPS (Weighted Average and Diluted) stood at -$16.04 in 2023, then surged by 73.3% to -$4.28 in 2024, then surged by 71.52% to -$1.22 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.22 for Q3 2025, versus -$1.25 for Q2 2025 and -$0.8 for Q1 2025.